Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-04
2005-10-04
Owens, Amelia Averill (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S277000, C546S318000, C546S342000
Reexamination Certificate
active
06951877
ABSTRACT:
The subject invention provides novel HMG-CoA-reductase inhibitors. In a preferred embodiment, the HMG-CoA reductase inhibitors of the subject invention can be deactivated to a primary inactive metabolite by hydrolytic enzymes. Compounds of the present invention can be advantageously used to treat patients suffering hypercholesterolemia.
REFERENCES:
patent: 5849749 (1998-12-01), Fey et al.
patent: 0 464 817 (1992-01-01), None
patent: WO 01 81328 (2001-11-01), None
patent: WO 01 85975 (2001-11-01), None
patent: WO 02 24689 (2002-03-01), None
Druzgala Pascal
Zhang Xiaoming
ARYx Therapeutics, Inc.
McDonnell Boehnen & Hulbert & Berghoff LLP
Owens Amelia Averill
LandOfFree
Materials and methods for treating hypercholesterolemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Materials and methods for treating hypercholesterolemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for treating hypercholesterolemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3480043